-
1
المؤلفون: Paul Cannon, Hannah Maguire, Elaine Y.L. Leung, Emma Clark
المصدر: Complementary Therapies in Medicine, Vol 57, Iss, Pp 102654-(2021)
Complementary Therapies in Medicineمصطلحات موضوعية: DFS, disease-free survival, Psychological intervention, PROSPERO, Prospective Register of Systematic Reviews, PsycINFO, Psychosocial Intervention, law.invention, Other systems of medicine, 0302 clinical medicine, Randomized controlled trial, law, 030212 general & internal medicine, RCT, randomized controlled trial, Randomized Controlled Trials as Topic, RoB 2, Cochrane risk-of-bias tool for randomized trials, FMD, fasting-mimicking diet, PFS, progression-free survival, CENTRAL, Cochrane Central Register of Controlled Trials, Meta-analysis, Female, PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses, Complementary and Manual Therapy, medicine.medical_specialty, MEDLINE, Breast Neoplasms, CINAHL, SIGN, The Scottish Intercollegiate Guidelines Network, Article, OS, overall survival, 03 medical and health sciences, Breast cancer, Behavioural therapy, Internal medicine, medicine, Humans, CINAHL, the Cumulative Index to Nursing and Allied Health Literature the WHO ICTRP:International Clinical Trials Registry Platform Portal, Exercise, Advanced and Specialized Nursing, business.industry, Physical activity, Cancer, medicine.disease, QoL, quality of life, Diet, Psychotherapy, Complementary and alternative medicine, Systematic review, Neoplasm, business, 030217 neurology & neurosurgery, RZ201-999, REML, random-effects restricted maximum likelihood
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2dccc0d14d9ce09de69642ef9ea420Test
https://eprints.gla.ac.uk/227465/1/227465.pdfTest -
2
المؤلفون: Jules Gregory, Isabelle Boutron, Valérie Vilgrain, Maxime Ronot, Perrine Créquit
المصدر: JHEP Reports, Vol 3, Iss 1, Pp 100196-(2021)
JHEP Reportsمصطلحات موضوعية: medicine.medical_specialty, Registration, Hepatocellular carcinoma, MEDLINE, Context (language use), law.invention, Randomized controlled trial, Bias, Outcome reporting, law, Internal medicine, Internal Medicine, medicine, Immunology and Allergy, UMIN-CTR, University Hospital Medical Information Network Clinical Trials registry, lcsh:RC799-869, RCTs, randomised controlled trials, Randomised controlled trial, PO, primary outcome, Hepatology, business.industry, ChiCTR, Chinese Clinical Trial Registry, TACE, transarterial chemoembolisation, Gastroenterology, Primary outcome, Embolisation, Subject (documents), Clinical trial, CENTRAL, Cochrane Central Register of Controlled Trials, Reporting bias, Data extraction, ICMJE, International Committee of Medical Journal Editors, lcsh:Diseases of the digestive system. Gastroenterology, business, HCC, hepatocellular carcinoma, ICTRP, International Clinical Trials Registry Platform, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99e00c780cabf7c077b5ec70779435bcTest
http://www.sciencedirect.com/science/article/pii/S2589555920301300Test -
3
المؤلفون: Jaw-Yuan Wang, Wei-Chih Su, Hsiang-Lin Tsai, Hsiu-Chung Cheng, Tsung-Kun Chang
المصدر: Translational Oncology, Vol 14, Iss 7, Pp 101089-(2021)
Translational Oncologyمصطلحات موضوعية: Oncology, endocrine system diseases, TCF4, Transcription factor 4, Colorectal cancer, RR, relative risk, Review, I2, I-square, HbA1c, Hemoglobin A1c, ADM, antidiabetic medications, AGEs, advanced glycation end-products, SMAD3, Mothers against decapentaplegic homolog 3, US, United States, Impaired glucose tolerance, ADA, American Diabetes Association, Diabetes mellitus, 0302 clinical medicine, GREM1, Gremlin 1, SEPT9, septin 9, RC254-282, APC, Adenomatous polyposis coli, pCR, pathologic complete response, RFS, recurrence-free survival, Metformin, 030220 oncology & carcinogenesis, CRC, colorectal cancer, TCF7L2, Transcription Factor 7 Like 2, medicine.medical_specialty, CSCs, cancer stem cells, WNT, Wingless-related integration site, mTOR, mammalian target of rapamycin, BMI, Body mass index, GLUT1, glucose transporter 1, STZ, streptozotocin, EHMT2, Euchromatic Histone Lysine Methyltransferase 2, VEGFR2, vascular endothelial growth factor 2, mCRC, metastatic colorectal cancer, 03 medical and health sciences, NIDDM, non-insulin-dependent diabetes mellitus, PFS, Progression-free survival, ERFC, Emerging Risk Factors Collaboration, PKC, protein kinase C, KRAS, Kirsten rat sarcoma viral oncogene homolog, AKT, RAC-alpha serine/threonine-protein kinase, WFS1, Wolframin ER Transmembrane Glycoprotein, IGF, Insulin-Like Growth Factor, nutritional and metabolic diseases, medicine.disease, PPARG, Peroxisome Proliferator Activated Receptor Gamma, 030104 developmental biology, Hyperglycemia, TCF7L2, Oncological outcome, 0301 basic medicine, Cancer Research, TP53, tumor protein p53, FOLFOX, Folinic acid, Fluorouracil, Oxaliplatin, RPG, random plasma glucose, Cancer risk, DNA, deoxyribonucleic acid, DM, diabetes mellitus, HNF1B, Hepatocyte nuclear factor-1-beta, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, HR, hazard ratios, CENTRAL, Cochrane Central Register of Controlled Trials, GWAS, Genome-wide association studies, IGF1, Insulin-Like Growth Factor 1, HBP, hexosamine biosynthetic pathway, medicine.drug, PI3K, Phosphoinositide 3-kinases, KCNQ1, Potassium Voltage-Gated Channel Subfamily Q Member 1, EMT, epithelial mesenchymal transition, CAMK1D, Calcium/Calmodulin Dependent Protein Kinase ID, TTR, the time to recurrence, 2-h PG, 2-h plasma glucose, OS, overall survival, ROS, reactive oxygen species, IGFBPs, insulin-like growth factor-binding protein, Internal medicine, RAS, Rat sarcoma, medicine, FPG, fasting plasma glucose, PI3K/AKT/mTOR pathway, VTI1A, Vesicle Transport Through Interaction With T-SNAREs 1A, U.S.FDA, United States Food and Drug administration, OGTT, Oral Glucose Tolerance Test, business.industry, IGF2BP2, Insulin Like Growth Factor 2 MRNA Binding Protein 2, ACF, aberrant crypt foci, AMPK, Cancer, BMJ, British Medical Journal, CI, confidence interval, OR, odds ratio, AMPK, AMP-activated protein kinase, DKD, diabetic kidney disease, TP53INP1, Tumor Protein P53 Inducible Nuclear Protein 1, 5-FU, 5-fluorouracil, NEJM, The New England Journal of Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b748b9c71d9b30a48c845ddaf0de4297Test
https://doi.org/10.1016/j.tranon.2021.101089Test -
4
المؤلفون: Bradford D. Gessner, Judi Winkup, Justin R. Ortiz, Johanna Geraci, Dominik Mertz, Mark Loeb
المصدر: Vaccine
مصطلحات موضوعية: 0301 basic medicine, Review, 0302 clinical medicine, Pregnancy, Risk Factors, Pandemic, Risk of mortality, 030212 general & internal medicine, Pregnancy Complications, Infectious, RR, risk ratio, Mortality rate, Vaccination, CENTRAL, Cochrane Central Register of Controlled Trials, Hospitalization, Observational Studies as Topic, Treatment Outcome, Infectious Diseases, Meta-analysis, Molecular Medicine, Female, Risk, medicine.medical_specialty, Critical Care, 030106 microbiology, WHO, World Health Organization, 03 medical and health sciences, Intensive care, Internal medicine, Immunology and Microbiology(all), Influenza, Human, medicine, Pneumonia, Bacterial, Humans, Risk factor, Intensive care medicine, General Veterinary, General Immunology and Microbiology, business.industry, Public Health, Environmental and Occupational Health, Odds ratio, medicine.disease, NOS, Newcastle Ottawa Scale, Respiration, Artificial, Survival Analysis, veterinary(all), Influenza, CI, confidence interval, OR, odds ratio, Systematic review, ICU, intensive care units, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8caf7f359038efd2e97b1776cc13e590Test